Peter H. Bui, Ph.D. - Publications

2009 University of California, Los Angeles, Los Angeles, CA 

4 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2011 Quesada A, Bui PH, Homanics GE, Hankinson O, Handforth A. Comparison of mibefradil and derivative NNC 55-0396 effects on behavior, cytochrome P450 activity, and tremor in mouse models of essential tremor. European Journal of Pharmacology. 659: 30-6. PMID 21256842 DOI: 10.1016/j.ejphar.2011.01.004  0.8
2009 Bui PH, Hankinson O. Functional characterization of human cytochrome P450 2S1 using a synthetic gene-expressed protein in Escherichia coli. Molecular Pharmacology. 76: 1031-43. PMID 19713358 DOI: 10.1124/mol.109.057752  0.8
2009 Bui PH, Hsu EL, Hankinson O. Fatty acid hydroperoxides support cytochrome P450 2S1-mediated bioactivation of benzo[a]pyrene-7,8-dihydrodiol. Molecular Pharmacology. 76: 1044-52. PMID 19713357 DOI: 10.1124/mol.109.057760  0.8
2008 Bui PH, Quesada A, Handforth A, Hankinson O. The mibefradil derivative NNC55-0396, a specific T-type calcium channel antagonist, exhibits less CYP3A4 inhibition than mibefradil. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 36: 1291-9. PMID 18411403 DOI: 10.1124/dmd.107.020115  0.8
Show low-probability matches.